Abstract
Here, we used glucocorticoid as an apoptosis inducer to study how glucocorticoid could accelerate cartilage degeneration and the responsible signal pathway. Human chondrocytes were isolated from knee joints gave glucocorticoid of different concentrations for 24 h, 48 h, 72 h, or 1 week, and cell viability was determined. Next, Sox9, Collagen type II, Aggrecan protein expression and mRNA transcription were detected by western blot analysis and quantitative real-time PCR, respectively. Glucocorticoid could suppress chondrocyte growth at the concentration of 100 μM. When cultured with glucocorticoid, the expressions of Sox9, Col II, and Aggrecan were depressed time-dependent and dose-dependent, as well as the mRNA transcription. The glucocorticoid-induced p38 inactivation was one mechanism that may response for the inhibition of extracellular matrix synthesis, and these influences appeared earlier than the apoptosis effect.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00296-011-2091-8/MediaObjects/296_2011_2091_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00296-011-2091-8/MediaObjects/296_2011_2091_Fig2_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00296-011-2091-8/MediaObjects/296_2011_2091_Fig3_HTML.gif)
References
Bi W, Deng JM, Zhang Z et al (1999) Sox9 is required for cartilage formation. Nat Genet 22:85–89
Huang W, Zhou X, Lefebvre V et al (2000) Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9’s ability to transactivate a Col2a1 chondrocytes-specific enhancer. Mol Cell Biol 20:4149–4158
Shintani N, Hunziker EB (2007) Chondrogenic differentiation of bovine synovium: bone morphogenetic proteins 2 and 7 and transforming growth factor beta1 induce the formation of different types of cartilaginous tissue. Arthr Rheum 56:1869–1879
Sive JI, Baird P, Jeziorsk M et al (2002) Expression of chondrocyte markers by cells of normal and degenerated intervertebral discs. Mol Pathol 55:91–97
Aigner T, Gebhard PM, Schmid E et al (2003) SOX9 expression does not correlate with type II collagen expression in adult articular chondrocytes. Matrix Biol 24:363–372
Tchetina EV, Squires G, Poole AR (2005) Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions. J Rheumatol 35:876–886
Brew CJ, Clegg PD, Boot-Handford RP et al (2010) Gene expression in human chondrocytes in late OA is changed in both fibrillated and intact cartilage without evidence of generalised chondrocyte hypertrophy. Ann Rheum Dis 69:234–240
Cucchiarini M, Thurn T, Weimer A et al (2007) Restoration of the extracellular matrix in human osteoarthritic articular cartilage by overexpression of the transcription factor SOX9. Arthr Rheum 29:158–167
Sanchez C, Deberg MA, Piccardi N et al (2005) Subchondral bone osteoblasts induce phenotypic changes in human osteoarthritic chondrocytes. Osteoarthr Cartil 13:988–997
Paul R, Haydon RC, Cheng H et al (2003) Potential use of Sox9 gene therapy for intervertebral degenerative disc disease. Spine 28:755–763
Liu XY, Yang SH, Liang CY et al (2007) Construction of recombinant baculovirus Ac-CMV-hSox9 for gene therapy of intervertebral disc degeneration. Clin J Traumatol 22:94–100
Yoon ST, Kim K, Li J et al (2003) The effect of bone morphogenetic protein-2 on rat intervertebral disc cells in vitro. Spine 28:1773–1780
Li Y, Tew SR, Russell AM et al (2004) Transduction of passaged human articular chondrocytes with adenoviral, retroviral, and lentiviral vectors and the effects of enhanced expression of Sox9. Tissue Eng 10:575–584
Majumdar MK, Chockalingam PS, Bhat RA et al (2008) Immortalized mouse articular cartilage cell lines retain chondrocyte phenotype and respond to both anabolic factor BMP-2 and pro-inflammatory factor IL-1. J Cell Physiol 215:68–76
Bernard H, Jolelyne D (1987) Effects of dexamethasome on the growth of culture rabbit articular chondrocytes, relation with the nuclear glucocorticoid- recepter complex. Ann Rheum Dis 46:146–152
Roman-Blas JA, Stokes DG, Jimenez SA (2007) Modulation of TGF-beta signaling by proinflammatory cytokines in articular chondrocytes. Osteoarthr Cartil 15:1367–1377
Hoffman LM, Weston AD, Underhill TM (2003) Molecular mechanisms regulating chondroblast differentiation. J Bone Joint Surg (Am) 85:124–132
Chandler GN, Wright V (1958) Deleterilous effects of intra-articullar hydrocortisone. Lancet 2:661–663
Nehrer S, Specttor M, Minas T (1999) Histologic analysis of tissue after failed cartilage repair procedures. J Clin Orthop 365:149–162
Acknowledgments
The authors would like to thank Mr. Shangha Pan, Mr. Bowen Dong, Mr. Guolong Ma and Ms. You Zhou for technically supports.
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Song, Y.W., Zhang, T. & Wang, W.B. Gluococorticoid could influence extracellular matrix synthesis through Sox9 via p38 MAPK pathway. Rheumatol Int 32, 3669–3673 (2012). https://doi.org/10.1007/s00296-011-2091-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-011-2091-8